Latest Insider Transactions at Pfizer Inc (PFE)
This section provides a real-time view of insider transactions for Pfizer Inc (PFE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PFIZER INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PFIZER INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2023
|
Michael Mc Dermott Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
14,178
+13.22%
|
$311,916
$22.89 P/Share
|
|
Feb 25
2023
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
22,836
-10.27%
|
$959,112
$42.59 P/Share
|
|
Feb 25
2023
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
33,654
+22.42%
|
$740,388
$22.89 P/Share
|
|
Feb 25
2023
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
54,868
-14.05%
|
$2,304,456
$42.59 P/Share
|
|
Feb 25
2023
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
72,984
+25.87%
|
$1,605,648
$22.89 P/Share
|
|
Feb 25
2023
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
43,419
-12.32%
|
$1,780,179
$41.75 P/Share
|
|
Feb 25
2023
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
26,389
-16.34%
|
$1,081,949
$41.75 P/Share
|
|
Feb 25
2023
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
37,078
-9.48%
|
$1,520,198
$41.75 P/Share
|
|
Feb 24
2023
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-2.15%
|
$14,760
$41.75 P/Share
|
|
Feb 23
2023
|
Jennifer B. Damico SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
3,103
+15.64%
|
-
|
|
Feb 22
2023
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
42,759
-35.43%
|
$1,838,637
$43.04 P/Share
|
|
Feb 22
2023
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
57,032
+45.97%
|
$1,710,960
$30.17 P/Share
|
|
Feb 22
2023
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
59,298
-16.01%
|
$2,549,814
$43.04 P/Share
|
|
Feb 22
2023
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
76,043
+28.0%
|
$2,281,290
$30.17 P/Share
|
|
Feb 22
2023
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
11,465
-18.57%
|
$492,995
$43.04 P/Share
|
|
Feb 22
2023
|
Payal Sahni Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,209
+31.76%
|
$456,270
$30.17 P/Share
|
|
Feb 22
2023
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,036
-5.74%
|
$431,548
$43.04 P/Share
|
|
Feb 22
2023
|
Michael Mc Dermott Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
13,307
+13.01%
|
$399,210
$30.17 P/Share
|
|
Feb 22
2023
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
19,878
-10.96%
|
$834,876
$42.38 P/Share
|
|
Feb 22
2023
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
23,737
-11.54%
|
$1,020,691
$43.04 P/Share
|
|
Feb 22
2023
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
31,558
+22.85%
|
$946,740
$30.17 P/Share
|
|
Feb 22
2023
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
32,592
-7.69%
|
$1,368,864
$42.38 P/Share
|
|
Feb 22
2023
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
61,994
-14.96%
|
$2,603,748
$42.38 P/Share
|
|
Feb 22
2023
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
7,944
-19.57%
|
$341,592
$43.04 P/Share
|
|
Feb 22
2023
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
10,456
+32.63%
|
$313,680
$30.17 P/Share
|
|
Dec 16
2022
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
222,328
+23.5%
|
$5,780,528
$26.53 P/Share
|
|
Dec 14
2022
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
101,658
+24.89%
|
$2,643,108
$26.53 P/Share
|
|
Nov 07
2022
|
Mikael Dolsten President R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
79,108
+8.89%
|
$2,689,672
$34.44 P/Share
|
|
Jun 07
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
4,218
-28.0%
|
$223,554
$53.96 P/Share
|
|
May 31
2022
|
David M Denton Chief Financial Officer & EVP |
BUY
Grant, award, or other acquisition
|
Direct |
61,275
+49.64%
|
-
|
|
May 16
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
4,000
-20.98%
|
$200,000
$50.5 P/Share
|
|
May 13
2022
|
Payal Sahni Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,408
-7.5%
|
$68,992
$49.84 P/Share
|
|
May 12
2022
|
Douglas M Lankler Executive Vice President |
SELL
Open market or private sale
|
Direct |
38,273
-32.69%
|
$1,875,377
$49.41 P/Share
|
|
May 12
2022
|
William R Carapezzi Jr Executive Vice President |
SELL
Open market or private sale
|
Direct |
32,908
-46.31%
|
$1,645,400
$50.0 P/Share
|
|
May 11
2022
|
Sally Susman Executive Vice President |
SELL
Bona fide gift
|
Direct |
5,000
-4.02%
|
-
|
|
May 11
2022
|
Mikael Dolsten President R&D |
SELL
Open market or private sale
|
Direct |
63,902
-2.83%
|
$3,131,198
$49.34 P/Share
|
|
Mar 31
2022
|
William Pao Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
115,897
+50.0%
|
-
|
|
Mar 03
2022
|
Mikael Dolsten President R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
102,460
+12.04%
|
$3,381,180
$33.03 P/Share
|
|
Feb 28
2022
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,049
-5.3%
|
$48,254
$46.94 P/Share
|
|
Feb 28
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
740
-3.75%
|
$34,040
$46.94 P/Share
|
|
Feb 28
2022
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,384
-1.84%
|
$63,664
$46.94 P/Share
|
|
Feb 28
2022
|
William R Carapezzi Jr Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,795
-2.46%
|
$82,570
$46.94 P/Share
|
|
Feb 26
2022
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,824
-10.4%
|
$1,025,728
$47.72 P/Share
|
|
Feb 26
2022
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
29,744
-9.18%
|
$1,397,968
$47.72 P/Share
|
|
Feb 26
2022
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
6,402
-12.92%
|
$313,698
$49.18 P/Share
|
|
Feb 26
2022
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
9,713
+27.11%
|
$242,825
$25.6 P/Share
|
|
Feb 26
2022
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
9,398
-27.56%
|
$460,502
$49.18 P/Share
|
|
Feb 26
2022
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
12,716
+39.6%
|
$317,900
$25.6 P/Share
|
|
Feb 26
2022
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
21,199
-11.62%
|
$1,038,751
$49.18 P/Share
|
|
Feb 26
2022
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,317
+23.36%
|
$732,925
$25.6 P/Share
|